MeCure Industries Reports 140% Profit Surge in 2025

MeCure Industries Plc released its audited full-year results for the period ending December 31, 2025, reporting a pre-tax profit of N7.93 billion, which represents a 140.18% increase from the N3.30 billion recorded in 2024. The company's tax grew by 177.5% year-on-year, reaching N6.463 billion, the highest in three years.

The total revenue for the year rose to N77.69 billion, a 68.80% increase from N46.03 billion in the previous year, indicating strong top-line expansion across its pharmaceutical manufacturing and distribution operations. The board has recommended a dividend payout of N0.32 per ordinary share, subject to shareholder approval, which is a 113.33% increase compared to the N0.15 paid in the 2024 financial year.

This impressive bottom-line growth was driven by strong revenue expansion, which helped absorb elevated direct costs and operational expenses. The company's total assets grew by 49.45% to N81.96 billion, supporting higher property, plant, equipment, inventory, and trade receivables.